We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NVCR market cap is 1.59B. The company's latest EPS is USD -1.9132 and P/E is -7.66.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 126.05M | 127.32M | 133.78M | 138.5M | 150.36M |
Operating Income | -61.75M | -56.85M | -53.9M | -40.91M | -32.93M |
Net Income | -57.42M | -49.49M | -47.08M | -38.76M | -33.38M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 351.32M | 494.37M | 535.03M | 537.84M | 509.34M |
Operating Income | -1.83M | 30.4M | -44.33M | -89.52M | -232.87M |
Net Income | -7.23M | 19.81M | -58.35M | -92.53M | -207.04M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.16B | 1.15B | 1.15B | 1.12B | 1.21B |
Total Liabilities | 743.33M | 752.65M | 783.63M | 762.07M | 850.42M |
Total Equity | 415.68M | 393.7M | 362.5M | 359.36M | 361.75M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 479.45M | 1.05B | 1.14B | 1.19B | 1.15B |
Total Liabilities | 261.66M | 575.46M | 729M | 750.48M | 783.63M |
Total Equity | 217.79M | 476.53M | 410.49M | 441.17M | 362.5M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -39.46M | -58.78M | -73.34M | -31.57M | -33.29M |
Investing | 68.39M | 85.65M | 184.15M | 246.22M | -128.22M |
Financing | 12.71M | 13.88M | 15.79M | 213k | 87.53M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 26.62M | 99.15M | 82.76M | 30.79M | -73.34M |
Investing | -51.67M | -472.85M | -144.83M | -139.96M | 184.15M |
Financing | 61.68M | 440.21M | 25.7M | 15.49M | 15.79M |
Market Cap | 1.59B |
Price to Earnings Ratio | -7.66 |
Price to Sales Ratio | 3.11 |
Price to Cash Ratio | 6.59 |
Price to Book Ratio | 4.38 |
Dividend Yield | - |
Shares Outstanding | 108.22M |
Average Volume (1 week) | 758.39k |
Average Volume (1 Month) | 726.3k |
52 Week Change | 5.62% |
52 Week High | 24.735 |
52 Week Low | 10.87 |
Spread (Intraday) | 0.46 (3.09%) |
Company Name | NovoCure Ltd |
Address |
no 4 the forum jersey JE2 4UF |
Website | https://www.novocure.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions